GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
M

MedCap AB (publ) MCAP.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

554.50

-1.16%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

At a glance

Figures in SEK, from our data supplier.

FY2025

Revenue

SEK 2.11bn

FY2016FY2025

Net income

SEK 219.8m

FY2016FY2025

Free cash flow

SEK 280.5m

FY2016FY2025

Shareholders' equity

SEK 1.45bn

FY2016FY2025

Income statement

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
RevenueSEK 2.11bnSEK 1.81bnSEK 1.59bnSEK 1.11bnSEK 916.3mSEK 817.4mSEK 757.1mSEK 709.0mSEK 411.2mSEK 851.7m
Research and developmentSEK 57.6mSEK 44.2mSEK 14.5mSEK 34.0mSEK 20.1mSEK 19.9mSEK 31.2mSEK 29.0mSEK 8.7m—
Operating incomeSEK 300.2mSEK 272.3mSEK 227.5mSEK 170.9mSEK 127.0mSEK 89.1mSEK 83.2mSEK 47.8mSEK 18.2m−SEK 4.0m
Net incomeSEK 219.8mSEK 207.4mSEK 172.2mSEK 117.6mSEK 96.5mSEK 60.9mSEK 53.7mSEK 600,000SEK 2.1mSEK 73,000
Diluted earnings per share14.6513.9511.587.946.524.123.990.040.160.01

Balance sheet

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Total assetsSEK 2.61bnSEK 1.99bnSEK 1.66bnSEK 1.43bnSEK 1.17bnSEK 1.08bnSEK 842.3mSEK 668.9mSEK 600.2mSEK 563.2m
Cash and short-term investmentsSEK 370.4mSEK 370.1mSEK 188.2mSEK 236.2mSEK 139.7mSEK 146.5mSEK 20.6mSEK 56.6mSEK 61.3mSEK 42.6m
Total liabilitiesSEK 1.15bnSEK 703.2mSEK 635.1mSEK 570.6mSEK 471.8mSEK 479.3mSEK 509.5mSEK 395.1mSEK 332.5mSEK 270.9m
DebtSEK 482.9mSEK 358.0mSEK 261.2mSEK 340.0mSEK 256.9mSEK 263.8mSEK 324.9mSEK 159.7mSEK 175.1mSEK 138.2m
Shareholders' equitySEK 1.45bnSEK 1.28bnSEK 1.02bnSEK 856.3mSEK 696.0mSEK 595.7mSEK 327.8mSEK 271.3mSEK 264.8mSEK 270.9m
Shares outstanding15m15m15m15m15m15m13m13m13m13m

Cash flow

Fiscal years

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operationsSEK 342.7mSEK 360.0mSEK 228.0mSEK 85.5mSEK 116.3mSEK 115.6mSEK 71.4mSEK 90.6mSEK 27.3mSEK 81.5m
Capital spending−SEK 62.2m−SEK 66.2m−SEK 39.3m−SEK 44.3m−SEK 60.9m−SEK 24.4m−SEK 30.3m−SEK 34.2m−SEK 18.0m−SEK 36.7m
Free cash flowSEK 280.5mSEK 293.8mSEK 188.7mSEK 41.2mSEK 55.4mSEK 91.2mSEK 41.1mSEK 56.4mSEK 9.3mSEK 44.7m

Latest quarters

By quarter end

Jun 2026Mar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024
RevenueSEK 606.3mSEK 556.6mSEK 591.0mSEK 501.5mSEK 521.7mSEK 493.8mSEK 474.2mSEK 413.0m
Operating incomeSEK 101.9mSEK 79.2mSEK 89.1mSEK 71.4mSEK 75.8mSEK 66.6mSEK 56.8mSEK 65.7m
Net incomeSEK 69.1mSEK 55.9mSEK 64.6mSEK 51.2mSEK 53.6mSEK 50.5mSEK 41.5mSEK 52.9m
Diluted earnings per share4.613.734.313.413.573.372.793.56
Cash from operationsSEK 122.0mSEK 51.0mSEK 151.0mSEK 61.0mSEK 73.0mSEK 55.0mSEK 126.0mSEK 70.0m
Capital spending−SEK 15.0m−SEK 4.0m−SEK 23.0m−SEK 3.0m−SEK 12.0m−SEK 14.0m−SEK 20.0m−SEK 11.0m
Free cash flowSEK 107.0mSEK 47.0mSEK 128.0mSEK 58.0mSEK 61.0mSEK 41.0mSEK 106.0mSEK 59.0m
Total assetsSEK 2.78bnSEK 2.70bnSEK 2.61bnSEK 2.48bnSEK 2.09bnSEK 2.03bnSEK 1.99bnSEK 1.89bn
Cash and short-term investmentsSEK 286.3mSEK 394.4mSEK 370.4mSEK 358.7mSEK 335.1mSEK 315.2mSEK 370.1mSEK 287.7m
DebtSEK 249.7mSEK 261.3mSEK 482.9mSEK 506.1mSEK 335.1mSEK 347.3mSEK 358.0mSEK 347.5m
Shareholders' equitySEK 1.59bnSEK 1.53bnSEK 1.45bnSEK 1.40bnSEK 1.36bnSEK 1.31bnSEK 1.28bnSEK 1.19bn

Financial ratios

Data as of 10 Oct 2026

FY2025FY2024FY2023FY2022FY2021FY2020
Operating margin15.2%15.5%15.0%15.2%13.8%11.1%
Net margin10.4%11.5%10.8%10.6%10.5%7.5%
Return on equity15.1%16.2%16.8%13.7%13.9%10.2%
Return on assets8.4%10.4%10.4%8.2%8.3%5.6%
Free cash flow yield5.2%5.6%3.5%1.7%2.3%1.8%
Revenue growth16.7%13.8%42.8%21.3%12.1%8.0%
Earnings growth6.0%20.4%46.4%21.9%58.5%13.4%
Current ratio2.01x2.77x2.23x2.46x1.96x1.64x
Debt to equity0.18x0.09x0.14x0.25x0.16x0.25x
Equity ratio55.7%64.4%61.5%59.9%59.5%55.1%
Interest coverage10.17x14.77x15.25x10.27x13.45x9.96x
R&D as a share of sales2.7%2.4%0.9%3.1%2.2%2.4%
Buybacks as a share of market value-1.0%0.0%-0.4%-0.0%-0.0%-10.0%

Growth per year

Compound annual rate

3 years5 years10 years
Revenue23.8%20.9%9.9%
Operating income20.7%27.5%25.0%
Net income23.2%29.3%27.4%

Average margins

Over each period

1 year3 years5 years10 years
Operating margin14.6%14.7%14.2%11.5%
Net margin10.9%10.8%10.5%8.0%

Valuation history

At each fiscal year end

FY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Price to earnings37.143.129.127.327.355.934.8—287.2—
Price to sales3.94.93.22.92.94.22.51.51.50.6

Dividends and splits

Per share, in the currency the company pays

Paid for 0 years.

  • 10-to-1 reverse split · 27 Sept 2016

Sources and methodology

Data on this tab
Our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.